Cargando…
Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma
Characterized with a high recurrence rate and low detection rate, prevention is the best approach to reduce mortality in hepatocellular carcinoma (HCC). The overexpression of Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 2 (PREX2) is observed in various tumors, including HCC...
Autores principales: | Yang, Ming-Hui, Yen, Chia-Hung, Chen, Yen-Fu, Fang, Cheng-Chieh, Li, Chung-Hsien, Lee, Kuo-Jui, Lin, Yi-Hsiung, Weng, Chien-Hui, Liu, Tze-Tze, Huang, Shiu-Feng, Teh, Bin Tean, Chen, Yi-Ming Arthur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385191/ https://www.ncbi.nlm.nih.gov/pubmed/30796242 http://dx.doi.org/10.1038/s41598-018-36810-5 |
Ejemplares similares
-
Knockdown of PREX2a inhibits the malignant phenotype of glioma cells
por: Liu, Liang, et al.
Publicado: (2021) -
Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development
por: Yen, Chia-Hung, et al.
Publicado: (2017) -
Melanoma genome sequencing reveals frequent PREX2 mutations
por: Berger, Michael F., et al.
Publicado: (2012) -
MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma
por: Hung, Jung-Hsien, et al.
Publicado: (2018) -
Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)